首页

AD联系:2386470631

369打鱼

时间:2020-02-17 11:14:17 作者:真人正规 浏览量:21819

永久地址🥇 k-ag8.vip 🥇369打鱼欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见,见下图

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见,见下图

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

,如下图

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见

如下图

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

,如下图

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见,见图

369打鱼核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见。

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

369打鱼核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见。

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

1.欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见

2.核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

3.核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

4.欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见。

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见。369打鱼

展开全文
相关文章
真人老虎转转转

欧盟就人工合成反式白藜芦醇作为新型食品的安全性发布意见

体育注册送

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

....

九天网开户

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

....

国际老虎机网站

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

....

博乐体育网

核心提示:据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

食品伙伴网讯 据欧盟食品安全局(EFSA)消息,应欧盟委员会的要求,欧盟食品安全局就人工合成的反式白藜芦醇(trans-resveratrol)作为新型食品的安全性发布意见。

申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂,每日用量为150毫克/天。欧盟专家组经过评估认为,代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶,并且可能与CYP2C9代谢后的药物起反应。最后认为,按照规定条件使用反式白藜芦醇是安全的。

部分原文报道如下:

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% (w/w)。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

原文链接:<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>

....

相关资讯
热门资讯